Genetic Signatures
(ASX) GSS
Genetic Signatures Financials at a Glance
Market Cap
$18.40M
Revenue (TTM)
$30.74M
Net Income (TTM)
$33.86M
EPS (TTM)
$-0.05
P/E Ratio
-1.63
Dividend
$0.00
Beta (Volatility)
-0.07 (Low)
Dividend
$0.00
Beta (Volatility)
-0.07 (Low)
Price
$0.08
Volume
0
Open
$0.08
Price
$0.08
Volume
0
Open
$0.08
Previous Close
$0.08
Daily Range
$0.08 - $0.08
52-Week Range
$0.07 - $0.69
Dividend
$0.00
Beta (Volatility)
-0.07 (Low)
Price
$0.08
Volume
0
Open
$0.08
Previous Close
$0.08
Daily Range
$0.08 - $0.08
52-Week Range
$0.07 - $0.69
GSS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Genetic Signatures
Industry
Life Sciences Tools and Services
Sector
Health CareCEO
Allison Rossiter
Website
www.geneticsignatures.comHeadquarters
Newtown, NSW 2042, AU
GSS Financials
Key Financial Metrics (TTM)
Gross Margin
-80%
Operating Margin
-1%
Net Income Margin
-70%
Return on Equity
-23%
Return on Capital
-41%
Return on Assets
-23%
Earnings Yield
-61.35%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$18.40M
Shares Outstanding
227.14M
Volume
0
Short Interest
0.00%
Avg. Volume
302.42K
Financials (TTM)
Gross Profit
$7.78M
Operating Income
$18.48M
EBITDA
$16.08M
Operating Cash Flow
$12.29M
Capital Expenditure
$902.00K
Free Cash Flow
$13.19M
Cash & ST Invst.
$31.30M
Total Debt
$791.00K
Genetic Signatures Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$8.68M
+140.9%
Gross Profit
$6.61M
+30.0%
Gross Margin
-76.14%
N/A
Market Cap
$18.40M
N/A
Market Cap/Employee
$157.25K
N/A
Employees
117
N/A
Net Income
$6.37M
+39.2%
EBITDA
$7.78M
+30.1%
Quarterly Fundamentals
Net Cash
$29.22M
+61.3%
Accounts Receivable
$4.55M
+25.5%
Inventory
$8.54M
+5.4%
Long Term Debt
$188.00K
N/A
Short Term Debt
$465.00K
+3775.0%
Return on Assets
-22.98%
N/A
Return on Invested Capital
-40.89%
N/A
Free Cash Flow
$948.00K
+83.4%
Operating Cash Flow
$349.00K
+85.8%